Beta Bionics (BBNX) Operating Leases (2023 - 2026)

Beta Bionics has disclosed Operating Leases across 4 years of filings, most recently posting $5.1 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $5.1 million, down 6.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (down 6.92% YoY), and the FY2025 annual result was $5.4 million, down 6.3% from the prior year.
• Operating Leases came in at $5.1 million for Q1 2026 at Beta Bionics, down from $5.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $5.7 million in Q4 2024 to a low of $3.0 million in Q4 2023.
• The 4-year median for Operating Leases is $5.4 million (2025), against an average of $5.1 million.
• Across the five-year window, Operating Leases jumped 90.93% in 2024 and declined 6.92% in 2026, its largest moves.
• Beta Bionics' Operating Leases stood at $3.0 million in 2023, then surged by 90.93% to $5.7 million in 2024, then decreased by 6.3% to $5.4 million in 2025, then dropped by 5.44% to $5.1 million in 2026.
• The last three Operating Leases figures came in at $5.1 million (Q1 2026), $5.4 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.